Back
Pharming Group Vs. ProQR Therapeutics NV Industry Stock Comparison
Sell
42
PHAR
Pharming Group
Last Price:
8.12
Seasonality Move:
16.96%
Sell
42
PRQR
ProQR Therapeutics NV
Last Price:
3.50
Seasonality Move:
32.86%
Sell
42
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $8.96. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $3.49. The Score for PRQR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $8.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing slight selling pressure.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $3.49
The current trend is moderately bullish and PRQR is experiencing slight selling pressure.
PHAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 59.63 | Buy |
Chaikin Money Flow: | -3549 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.93 - 8.83) | Buy |
Bollinger Bands (100): | (7.59 - 8.65) | Buy |
PRQR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 64.95 | Buy |
Chaikin Money Flow: | -76229 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.38 - 3.1) | Buy |
Bollinger Bands (100): | (1.48 - 2.44) | Buy |
PHAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.79 | Buy |
20-day SMA: | 8.53 | Buy |
50-day SMA: | 8 | Buy |
200-day SMA: | 9.56 | Sell |
8-day EMA: | 8.83 | Buy |
20-day EMA: | 8.54 | Buy |
50-day EMA: | 8.26 | Buy |
200-day EMA: | 9.21 | Sell |
PRQR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.14 | Buy |
20-day SMA: | 2.37 | Buy |
50-day SMA: | 2.11 | Buy |
200-day SMA: | 2.03 | Buy |
8-day EMA: | 3.28 | Buy |
20-day EMA: | 2.66 | Buy |
50-day EMA: | 2.24 | Buy |
200-day EMA: | 2 | Buy |
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Pharming Group Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProQR Therapeutics NV Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |